HAL (France)open access
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)
PAOLA-1, 1, Time without significant symptoms or toxicity, 0, Health-related quality of life, Bevacizumab, Newly diagnosed advanced ovarian cancer, Olaparib
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 157612
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.